Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II
- 8 October 2004
- journal article
- clinical trial
- Published by Elsevier BV in Life Sciences
- Vol. 75 (21), 2505-2513
- https://doi.org/10.1016/j.lfs.2003.10.043
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Nitric Oxide-Endothelin-1 ConnectionHeart Failure Reviews, 2003
- Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profileLipids, 2002
- Comparative study of Venostasin® and Pycnogenol® in chronic venous insufficiencyPhytotherapy Research, 2002
- Diabetes mellitusJournal of Diabetes and its Complications, 2001
- Pine bark extract reduces platelet aggregationIntegrative Medicine, 2000
- Type 2 diabetesCoronary Artery Disease, 1999
- Endothelium-Dependent Vascular Effects of PycnogenolJournal of Cardiovascular Pharmacology, 1998
- Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damageExperimental and Clinical Endocrinology & Diabetes, 1997
- Increased Plasma Endothelin in NIDDM Patients With RetinopathyDiabetes Care, 1992
- Circulating and Tissue Endothelin Immunoreactivity in Advanced AtherosclerosisNew England Journal of Medicine, 1991